TP53 Alterations in Breast Cancer
Author Information
Author(s): T.I. Andersen, R. Holm, J.M. Nesland, K.R. Heimdall, L. Ottestad, A.-L. B0rresen
Primary Institution: The Norwegian Radium Hospital
Hypothesis
The study aims to determine the nature and frequency of TP53 mutations and p53 protein accumulation in breast carcinomas and their associations with clinical parameters.
Conclusion
TP53 alterations in primary breast carcinomas are associated with poor prognosis and various clinical parameters.
Supporting Evidence
- TP53 mutations were found in 21% of primary tumors and 31% of metastases.
- TP53 alterations were significantly associated with poor overall and disease-free survival.
- 22% of primary tumors showed nuclear accumulation of p53 protein.
Takeaway
This study looked at breast cancer samples to see if changes in a specific gene (TP53) could help predict how aggressive the cancer is.
Methodology
The study used constant denaturant gel electrophoresis (CDGE) to screen for TP53 mutations in breast carcinoma samples and analyzed associations with clinical parameters.
Limitations
The study may not account for mutations outside the screened regions of the TP53 gene.
Participant Demographics
The mean age at diagnosis was 56.6 years, with a range from 31.1 to 85.6 years.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website